TY - JOUR
AU - RECOVERY Collaborative Group
PY - 2021
DA - June
TI - Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
JO - The Lancet
EP - 1645
VL - 397
IS - 10285
DO - https://doi.org/10.1016/S0140-6736(21)00676-0
AB - In this study, we aimed to evaluate the effects of tocilizumab in adult patients admitted to hospital with COVID-19 with both hypoxia and systemic inflammation.
PB - Elsevier
UR - https://aura.abdn.ac.uk/handle/2164/16630
KW - Coronavirus (COVID-19)
KW - Hospital care
ER